Authors
Latest:
Patients With Cancer May Need Help Changing Their Eating ApproachesCaitlin Benda, MBA, MS, RD, CSO, LDN, a clinical oncology nutritionist supervisor at American Oncology Network, comments on different ways oncology nurses can assist patients in reaching their overall caloric intake.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Power of Palliative Care: How Oncology Nurses Can Increase ReferralsA nurse-driven palliative care referral intervention demonstrated preliminary success in increasing the number of patients who received this form of supportive care.
Latest:
Low and Maldonado on Leveraging Wearable Devices to Improve Inpatient AmbulationSarah Low RN, MSN, OCN, CMSRN; and Claudia Maldonado-Howell, RN, MSN, FNP, BS, CMSRN, discuss their research on wearable technology.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Menstrual Suppression Is a Valuable Component of HSCT Care for Premenopausal WomenMenstrual suppression can improve outcomes and quality of life in premenopausal women undergoing hematopoietic stem cell transplant.
Latest:
Oncology Drug Crash Course: Fam-Trastuzumab Deruxtecan-Nxki (Enhertu)After demonstrating significant efficacy as a third-line treatment for patients with metastatic HER2-positive breast cancer, fam-trastuzumab deruxtecan-nxki has gained approval from the FDA for 5 indications and is under investigation across solid tumors.
Latest:
Donna Catamero Discusses Managing Teclistamab-Induced CRS for Patients With Multiple MyelomaDonna Catamero, ANP-BC, OCN, CCRC, outlines best management strategies for treating patients receiving teclistamab who experience cytokine release syndrome.
Latest:
Adjuvant Mitotane Misses RFS End Point in Adrenocortical CarcinomaAdjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.
Latest:
Normalize the Clinical Trial Conversation"Clinical trials are the vital bridge between research and a drug’s eventual availability to patients."
Latest:
Ridad and McKaig Discuss Oncology Nurse Perceptions on Medical CannabisAlyssa Ridad BSN-RN, OCN; and Amanda McKaig, BSN, RN, OCN, discuss oncology nurse perceptions of medical cannabis.
Latest:
MPN-Associated Anemia: What Nurses Should Look Out ForOncology nurses should have open communication with patients and closely monitor their hemoglobin levels when dealing with patients with myelofibrosis who have or may have anemia.
Latest:
Patient Experience Programs Improve Overall Quality of CarePatient experience programs can improve quality of care and decrease organization costs, resulting in a more efficient and less expensive cancer care journey for patients.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
VCU Massey Cancer Center achieves comprehensive status from the National Cancer InstituteVCU Massey Cancer Center has been designated a Comprehensive Cancer Center by the National Cancer Institute (NCI), the nation’s principal authority on cancer research and training.
Latest:
Oncology Drug Crash Course: Olaparib (Lynparza)Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Latest:
Zanubrutinib May Affect the Heart Less Than Ibrutinib and Acalabrutinib in CLL/SLLZanubrutinib to treat chronic lymphocytic leukemia or small lymphocytic lymphoma was linked with fewer cardiac adverse effects compared with ibrutinib and acalabrutinib.
Latest:
Advice for New Nurse Practitioners Working With Patients With Endometrial CancerClosing their discussion, the panel shares advice for new nurse practitioners caring for patients who have endometrial cancer.
Latest:
Recipe For DisasterAn oncology social worker reflects on a day in the life and how the memory of her sister motivates her to tackle her work.
Latest:
Psychological Concerns in the Aftermath of a Breast Cancer Diagnosis and Treatment for Young AdultsReceiving a breast cancer diagnosis and undergoing treatment as a young adult takes a physical and emotional toll.
Latest:
Oncology Nurses Can Help Better Prevent Chronic Lymphedema With BIS TechnologySheila Ridner, PhD, RN, FAAN, discusses the implications of the PREVENT study and how oncology nurses can advocate for patients with breast cancer.
Latest:
Cedars-Sinai Launches New Division of Population Sciences ResearchNew Division in the Department of Biomedical Sciences Conducts Translational Research and Engages With Community to Help Reduce the Burden of Disease and Improve Quality of Life.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Elizabeth Loach on Integrating Frontline Staff in Nursing Task ForcesElizabeth Loach, MSN, APRN, CNS, AGCNS-BC, OCN, discusses the importance of including frontline nurses in nursing leadership task forces.
Latest:
Dispelling Nutrition Myths for Patients With CancerEntering the words nutrition and cancer into Google returns as many as 718 million hits. With an overabundance of opinions, it can be challenging to separate fact from fiction.
Latest:
How I Counsel Patients About Lung Cancer ScreeningA lung cancer screening navigator offers their perspective on shared decision-making.
Latest:
Oncology Drug Crash Course: Olaparib (Lynparza)Olaparib is an oral drug manufactured in 150-mg and 100-mg tablets. Olaparib is taken by mouth, twice daily. It can be taken without or without food.
Latest:
Determining the Cause of Bicytopenia in a Patient With Progressive Dyspnea"Differential diagnoses in patients with bicytopenia—particularly those with preserved platelets—are broad and require careful physical examination."
